A new independent report reveals that medication management solutions like Ochsner Digital Medicine deliver superior hypertension outcomes and long-term cost savings compared to other digital approaches
“Many of our young patients have complex medical problems in addition to sleep problems. Therefore, we are excited to have recently welcomed three new faculty members, each bringing a unique med...
Genetic counselors are experts in genetics and how it impacts our health and development. Learn more about who they are, what they do and how they may help you and your family....
Moderate alcohol use does not reduce cardiometabolic disease risk among veterans of European, African, or Hispanic ancestry, a new study suggests. The findings add to growing evidence that traditional research methods applied to drinking levels and certain disease outcomes have created illusory and misleading results. Heavy drinking is known to be linked to coronary heart disease (CHD) and type 2 diabetes (T2D). Traditional observational studies have, however, associated moderate drinking with the lowest risk and abstinence with a moderate risk (the U-curve or J-curve effect). In recent years, the U-curve has been increasingly attributed to confounding errors—when study results are distorted by other factors. In this case, the abstinence category is implicated since it establishes a false equivalence between study participants with widely differing risk factors (lifelong non-drinkers, those who stopped drinking for health or other alcohol-related problems, and those who falsely reporte
We’re faced with it every holiday season: delectable treats we “can’t resist” for one reason or another, thus we overindulge. And for those dealing with diabetes or high blood pressure, the holidays can be especially challenging. A Hackensack Meridian Health expert has some tips on how to enjoy and keep healthy.
Ananth Karumanchi, MD, professor of Medicine, director of the Renovascular Research Center and the Medallion Chair in Vascular Biology at Cedars-Sinai, will lead a multicenter, international research team to study how the placenta affects the heart health of mothers and babies and whether it is predictive of heightened lifelong cardiovascular disease risk.
In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults, more than half of all adults, are eligible for semagludtide for weight loss, diabetes management, or prevention of recurrent cardiovascular events.
UChicago Medicine's current clinic on Salt Creek Lane in Hinsdale will close Nov. 21, and open across the street in a new, larger facility Dec. 2.
Attend The Society of Thoracic Surgeons’ 2025 Annual Meeting, featuring late-breaking scientific research, thought-provoking lectures, cutting-edge technologies, and innovative cardiothoracic surgery products, January 24 – January 26, in Los Angeles.
Newly updated stroke prevention guidelines from the American Heart Association and American Stroke Association say women with endometriosis and women with early-onset menopause are at greater risk.
Recycled pacemakers can function as well as new devices, a University of Michigan-led study suggests. These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and middle-income countries, where many patients cannot afford the treatment.
On June 13, Bonnie Hutton became the first patient in Kentucky to receive a GORE TAMBE device. Since then, Sam Tyagi, M.D., a vascular surgeon at UK HealthCare, said they’ve already been able to complete four such surgeries with several more already scheduled.
Researchers at Children’s Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene therapy trial for Danon disease (DD), a rare, X-linked heart condition caused by a single gene mutation. The phase 1 trial was a collaboration between CHOP and the University of California, San Diego Medical Center, the University of Colorado, Anschutz Medical Center, Boston Children's Hospital and Rocket Pharmaceuticals. The data on the results of the RP-A501 Phase 1 trial, presented at a late breaking session today at the American Heart Association Scientific Sessions 2024 in Chicago, were also published in the New England Journal of Medicine.
Alcohol-related deaths in the U.S. nearly doubled from 1999 to 2020. The sharpest spike occurred among 25–34-year-olds (nearly fourfold), while individuals aged 55–64 had the highest rates. Men consistently had higher rates but women saw the largest proportional rise, with deaths increasing 2.5 times. Asian and Pacific Islander communities experienced the steepest ethnic increase, while the Midwest saw the greatest regional rise (2.5 times), followed by the Northeast, West, and South.
Cedars-Sinai has published a summary highlighting its research advances for November 2024.
Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center are the only New Jersey hospitals to achieve the Extracorporeal Life Support Organization’s (ELSO) Gold Level Center of Excellence in Life Support Award.
Alyssa Stolarik, RN, BSN, clinical coordinator of Cardiology at Hackensack Meridian Health Mountainside Medical Center, received the Second Best Research Poster Award at the American College of Cardiology (ACC) Quality Summit held in San Antonio, Texas. Her work, titled “Improving Compliance with Post-PCI Creatinine,” highlights significant advancements in the management of post-procedural care and patient outcomes. The research addresses the critical issue of acute kidney injury (AKI) post-percutaneous coronary intervention (PCI), demonstrating a marked reduction in risk-standardized AKI rates, which significantly surpasses national benchmarks.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right